Cell Viability Assays Market Research Report – Forecast to 2027

Global Cell Viability Assays Market Research Report: By Product (Consumables, Instruments), by Cell Type (Human Cells, Microbial Cells, Animal cells), by Application (Stem Cell Research & Others), End-User (Pharma Biotech Companies & Others)– Forecast Till 2027

ID: MRFR/LS/4930-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Global cell Viability Assays market is expected to grow significantly over the forecast period. It is estimated that the global cell Viability Assays market is expected to register a CAGR ~ 9.2% during the forecast period of 2018–2023.


Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.


Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market. For instance, in 2015, the National Institutes of Health invested around 1,429 million USD for stem cells research. Moreover, increasing focus on developing cell-based therapeutics boosts the growth of the market. However, the rising cost of the instruments may hamper the market growth during the assessment period.


Segmentation


The market has been segmented into products, cell type, applications, and end-user.


The market, on the basis of products, has been segmented into consumables and instruments.


The consumables segment has been further divided into reagents, assay kits, and microplates. The Assay kits segment has been further segmented into tetrazolium reduction assay kits, resazurin cell Viability Assays kits, calcein-Am cell Viability Assays kits and other assay kits. Furthermore, tetrazolium assay kits have been classified into MIT assay kits and other tetrazolium assay kits.


The instruments have been segmented into automated cell counters, flow cytometers, spectrophotometers, and cell imaging & analysis systems.


The market, by cell type, has been segmented into human cells, microbial cells, and animal cells.


The market, by applications, has been segmented into stem cell research, clinical & diagnostic applications, drug discovery & development, and others.


The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospital & diagnostic laboratories and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The cell Viability Assays market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European cell Viability Assays market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The cell Viability Assays market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cell Viability Assays market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton Dickinson & Company, Promega Corporation, Biotium, Abcam plc, Creative Bioarray, Biotek Instruments, and PerkinElmer are some of the key players in the global cell Viability Assays market.


Regional Market Summary


Global Cell Viability Assays Market Share (%), by Region, 2017


Cell Viability Assays Market Share


Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)


Geographically, the Americas is anticipated to dominate the global cell Viability Assays market owing to a well-developed healthcare sector, rising prevalence of infectious and chronic diseases and growing healthcare expenditure. According to an article published by the Centers for Medicare and Medicaid Services in August 2018, the US healthcare spending had reached USD 3.3 trillion in 2016. Europe is expected to hold the second largest position in the global cell Viability Assays market. The market growth in this region is attributed to the growing prevalence of chronic diseases and increasing healthcare expenditure. According to a report published by EU observer in September 2014, more than the one-third population of Europe above the age of 15 years in suffering from a chronic disease and 2 in every 3 people reaching the age of retirement have at least 2 chronic diseases.


Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising number of stem cell, proteomics, and genomics research activities. Also, increased expenditure in the healthcare sector is expected to boost the growth in this market.


On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.


Global Cell Viability Assays Market, by Products



  • Consumables



  • Reagents

  • Assay Kits

  • Tetrazolium reduction assay kits

  • MIT assay kits

  • Other Tetrazolium reduction assay kits

  • Resazurin cell Viability Assays kits

  • Calcein-Am cell Viability Assays kits

  • Other assay kits

  • Microplates



  • Instruments



  • Automated cell counters

  • Flow Cytometers

  • Spectrophotometers

  • Cell imaging and analysis systems


Global Cell Viability Assays Market, by Cell Type



  • Human Cells

  • Microbial Cells

  • Animal Cells


Global Cell Viability Assays Market, by Applications



  • Stem Cell research

  • Clinical and diagnostic applications

  • Drug discovery and development

  • Others


Global Cell Viability Assays Market, by End-user



  • Pharmaceutical and Biotechnology companies

  • Academic and research institutes

  • Hospital and diagnostic laboratories

  • Others


Global Cell Viability Assays Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific



  • Middle East & Africa



  • Middle East

  • Africa


Global Cell Viability Assays Market, by Key Players



  • Thermo Fisher Scientific

  • Merck KGaA

  • Bio-Rad Laboratories

  • G E Healthcare

  • Danaher Corporation

  • Becton, Dickinson and Company

  • Promega Corporation

  • Biotium

  • Abcam plc

  • Creative Bioarray

  • Biotek Instruments

  • PerkinElmer


Intended Audience



  • Pharmaceutical and Biopharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   9.2% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Products, Cell type, Applications, and End-user.
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton Dickinson & Company, Promega Corporation, Biotium, Abcam plc, Creative Bioarray, Biotek Instruments, and PerkinElmer
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Growing prevalence of chronic and infectious diseases
  • Growing availability of funds for cell-based research
  • Rising need of cell-based assays in research and development activities


  • Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Cell Viability Assays Market, by Product

    6.1 Introduction

    6.2 Consumables

    6.2.1 Reagents

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.2 Assay Kits

    6.2.2.1 Tetrazolium Reduction Assay Kits

    6.2.2.1.1 MIT Assay Kits

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.2.1.2 Other Tetrazolium Assay Kits

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.2.2 Resazurin Cell Viability Assay Kits

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.2.3 Calcein-Am Cell Viability Assay Kits

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.2.4 Other Assay Kits

    6.2.3 Microplates

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Instruments

    6.3.1 Automated Cell Counters

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.2 Flow Cytometers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.3 Spectrophotometers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.4 Cell Imaging and Analysis Systems

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Cell Viability Assays Market, by Cell Type

    7.1 Introduction

    7.2 Human Cells

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Microbial Cells

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Animal Cells

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Cell Viability Assays Market, by Application

    8.1 Introduction

    8.2 Stem Cell Research

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Clinical and Diagnostic Applications

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Drug Discovery and Development

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Others

    Chapter 9. Global Cell Viability Assays Market, by End-User

    9.1 Pharmaceutical and Biotechnology Companies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.2 Academic and Research Institutes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Hospital and Diagnostic Centers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Others

    Chapter 10. Global Cell Viability Assays Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia-Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 South Korea

    10.4.6 Rest of Asia-Pacific

    10.5 Middle East & Africa

    10.5.1 Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Thermo Fisher Scientific

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Merck KGaA

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Bio-Rad Laboratories

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 GE Healthcare

    12.4.1 Company Overview

    12.4.2 Product Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Danaher Corporation

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 Becton, Dickinson and Company

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Promega Corporation

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Biotium

    12.8.1 Overview

    12.8.2 Product Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Abcam plc

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Creative Bioarray

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Biotek Instruments

    12.11.1 Overview

    12.11.2 Product Overview

    12.11.3 Financials

    12.11.4 Key Developments

    12.11.5 SWOT Analysis

    12.12 PerkinElmer

    12.12.1 Overview

    12.12.2 Product Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s Viewpoint

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Predictions for the Cell Viability Assays Industry

    Chapter 14. Appendix


    LIST OF TABLES

    Table 1 Global Cell Viability Assays Market Synopsis, 2020-2027

    Table 2 Global Cell Viability Assays Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Cell Viability Assays Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 5 Global Cell Viability Assays Market, by Cell Type, 2020-2027(USD Million)

    Table 6 Global Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 7 Global Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 8 North America: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 9 North America: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 10 North America: Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 11 North America: Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 12 US: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 13 US: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 14 US: Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 15 US: Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 16 Canada: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 17 Canada: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 18 Canada: Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 19 Canada: Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 20 South America: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 21 South America: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 22 South America: Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 23 South America: Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 24 Europe: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 25 Europe: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 26 Europe: Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 27 Europe: Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 28 Western Europe: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 29 Western Europe: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 30 Western Europe: Cell Viability Assays Market, by Application, 2020-2027 (USD

    Million)

    Table 31 Western Europe: Cell Viability Assays Market, by End-User, 2020-2027 (USD

    Million)

    Table 32 Eastern Europe: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 33 Eastern Europe: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 34 Eastern Europe: Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 35 Eastern Europe: Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 36 Asia-Pacific: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 37 Asia-Pacific: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 38 Asia-Pacific: Cell Viability Assays Market, by Application, 2020-2027 (USD Million)

    Table 39 Asia-Pacific: Cell Viability Assays Market, by End-User, 2020-2027 (USD Million)

    Table 40 Middle East & Africa: Cell Viability Assays Market, by Product, 2020-2027 (USD Million)

    Table 41 Middle East & Africa: Cell Viability Assays Market, by Cell Type, 2020-2027 (USD Million)

    Table 42 Middle East & Africa: Cell Viability Assays Market, by Application, 2020-2027 (USD

    Million)

    Table 43 Middle East & Africa: Cell Viability Assays Market, by End-User, 2020-2027 (USD

    Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Cell Viability Assays Market

    Figure 3 Segmentation Market Dynamics for Global Cell Viability Assays Market

    Figure 4 Global Cell Viability Assays Market Share, by Product, 2020

    Figure 5 Global Cell Viability Assays Market Share, by Cell Type, 2020

    Figure 6 Global Cell Viability Assays Market Share, by Application, 2020

    Figure 7 Global Cell Viability Assays Market Share, by End-User, 2020

    Figure 8 Global Cell Viability Assays Market Share, by Region, 2020

    Figure 9 North America: Cell Viability Assays Market Share, by Country, 2020

    Figure 10 Europe: Cell Viability Assays Market Share, by Country, 2020

    Figure 11 Asia-Pacific: Cell Viability Assays Market Share, by Country, 2020

    Figure 12 Middle East & Africa: Cell Viability Assays Market Share, by Country, 2020

    Figure 13 Global Cell Viability Assays Market: Company Share Analysis, 2020 (%)

    Figure 14 Thermo Fisher Scientific: Key Financials

    Figure 15 Thermo Fisher Scientific: Segmental Revenue

    Figure 16 Thermo Fisher Scientific: Geographical Revenue

    Figure 17 Merck KGaA: Key Financials

    Figure 18 Merck KGaA: Segmental Revenue

    Figure 19 Merck KGaA: Geographical Revenue

    Figure 20 Bio-Rad Laboratories: Key Financials

    Figure 21 Bio-Rad Laboratories: Segmental Revenue

    Figure 22 Bio-Rad Laboratories: Geographical Revenue

    Figure 23 G E Healthcare: Key Financials

    Figure 24 G E Healthcare: Segmental Revenue

    Figure 25 G E Healthcare: Geographical Revenue

    Figure 26 Danaher Corporation: Key Financials

    Figure 27 Danaher Corporation: Segmental Revenue

    Figure 28 Danaher Corporation: Geographical Revenue

    Figure 29 Becton, Dickinson and Company: Key Financials

    Figure 30 Becton, Dickinson and Company: Segmental Revenue

    Figure 31 Becton, Dickinson and Company: Geographical Revenue

    Figure 32 Promega Corporation: Key Financials

    Figure 33 Promega Corporation: Segmental Revenue

    Figure 34 Promega Corporation: Geographical Revenue

    Figure 35 Biotium: Key Financials

    Figure 36 Biotium: Segmental Revenue

    Figure 37 Biotium: Geographical Revenue

    Figure 38 Abcam plc: Key Financials

    Figure 39 Abcam plc: Segmental Revenue

    Figure 40 Abcam plc: Geographical Revenue

    Figure 41 Creative Bioarray: Key Financials

    Figure 42 Creative Bioarray: Segmental Revenue

    Figure 43 Creative Bioarray: Geographical Revenue

    Figure 44 Biotek Instruments: Key Financials

    Figure 45 Biotek Instruments: Segmental Revenue

    Figure 46 Biotek Instruments: Geographical Revenue

    Figure 47 PerkinElmer: Key Financials

    Figure 48 PerkinElmer: Segmental Revenue

    Figure 49 PerkinElmer: Geographical Revenue